bioAffinity Technologies (BIAF) Share-based Compensation (2021 - 2026)
bioAffinity Technologies (BIAF) reported Share-based Compensation of $14340.0 for Q1 2026, down 95.61% year-over-year from $326616.0 in Q1 2025, and down 78.31% quarter-over-quarter from $66119.0 in Q4 2025.
bioAffinity Technologies (BIAF) Share-based Compensation (2021 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has 6 years of Share-based Compensation data on file, last reported at $14340.0 in Q1 2026.
- Share-based Compensation for Q1 2026 came in at $14340.0, down 95.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $359198.0 (down 65.25% YoY), and the FY2025 annual result was $671474.0, down 32.15% from the prior year.
- Share-based Compensation slipped to $14340.0 in Q1 2026 per BIAF's latest filing, from $66119.0 in the prior quarter.
- Over five years, Share-based Compensation peaked at $326616.0 in Q1 2025 and troughed at $14340.0 in Q1 2026.
- A 5-year average of $151277.0 and a median of $157613.0 in 2023 frame the typical range for Share-based Compensation.
- The sharpest annual moves came in 2023 and 2026: Share-based Compensation surged 538.01% in 2023, then slumped 95.61% in 2026.
- A 5-year view of Share-based Compensation shows it stood at $36847.0 in 2022, then surged by 536.44% to $234510.0 in 2023, then declined by 0.18% to $234087.0 in 2024, then slumped by 71.75% to $66119.0 in 2025, then sank by 78.31% to $14340.0 in 2026.
- Business Quant data shows BIAF's Share-based Compensation at $14340.0 in Q1 2026, $66119.0 in Q4 2025, and $67132.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 20.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 83.00 Mn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 58.00 Mn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 16.34 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 32.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 95.11 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 65.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 60.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 5.47 Mn |
| 10 | bioAffinity Technologies | 2.08 Mn | -1.02 Mn | - | 14,340.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14,340.00 |
| Mar 31, 2026 | 14,340.00 |
| Dec 31, 2025 | 66,119.00 |
| Dec 31, 2025 | 66,119.00 |
| Sep 30, 2025 | 67,132.00 |
| Sep 30, 2025 | 67,132.00 |
| Jun 30, 2025 | 211,607.00 |
| Jun 30, 2025 | 211,607.00 |
| Mar 31, 2025 | 326,616.00 |
| Mar 31, 2025 | 326,616.00 |
| Dec 31, 2024 | 234,087.00 |
| Dec 31, 2024 | 234,087.00 |
| Sep 30, 2024 | 185,687.00 |
| Sep 30, 2024 | 185,687.00 |
| Jun 30, 2024 | 287,294.00 |
| Jun 30, 2024 | 287,294.00 |
| Mar 31, 2024 | 282,613.00 |
| Mar 31, 2024 | 282,613.00 |
| Dec 31, 2023 | 234,510.00 |
| Dec 31, 2023 | 234,510.00 |